Researchers at MIT(Cambridge,MA,USA;www.web.mit.edu) and Boston University (Boston,MA,USA; www.bu.edu) have developed a groundbreaking innovation: a smart pill,about the size of a blueberry,that could revolutionize the way inflammatory bowel diseases(IBDs) are diagnosed and treated.

This pioneering device is the first ingestible technology that can automatically identify and relay real time data about critical biological indicators of potential complications.

The latest work significantly advances earlier research with the current pill being more than six times smaller than the earlier prototype, conforming to safe,ingestible dosage forms available in the market.